Andrea Papait obtained his Degree in Biology from the University of Milan Bicocca. During his undergraduate, he pursued his thesis at the European Institute of Oncology in Milan, where he remained for a one-year fellowship after obtaining his degree. He subsequently obtained his doctorate in Biotechnology in Translational Medicine at the University of Genoa in the laboratory of Professor Ranieri Cancedda with a thesis on allogeneic platelet derivatives as new tools for the treatment of diabetic foot ulcers. During his Ph.D., he also conducted research as a visiting researcher at the European Space Agency, where he studied the effects of various molecules, including lipocalin 2, on bone mass preservation in a microgravity environment as part of the "In vitro bone" project.

Following his Ph.D., he conducted research as a visiting postdoc in Professor David Kaplan's laboratory at Tufts University in Boston. Here, his research focused on the application of cytokine-functionalized sericin scaffolds for treating diseases related to immune system dysregulation.

Since November 2018 Dr. Papait is enrolled as a post-doc researcher in the Centro di Ricerca E. Menni - Fondazione Poliambulanza (Brescia), directed by Professor Ornella Parolini. His studies have significantly contributed to the understanding of the immunomodulatory properties of mesenchymal stromal cells isolated from placental tissues, and of their derivatives such as their secretome, and how these contribute to tissue regeneration. Since January 2022 he is an Assistant Professor (RTDA) at the Università Cattolica del Sacro Cuore.